2024-03-29T04:42:25Z
http://repoint.unil.ch/oaiprovider/
oai:serval.unil.ch:BIB_25296
2024-03-23T02:01:22Z
serval:BIB_25296
Cardiovascular hazard of selective COX-2 inhibitors: myth or reality?
12904159
Chiolero
A.
author
Maillard
M.P.
author
Burnier
M.
author
article
2002-05
Expert opinion on drug safety
1474-0338
1474-0338
journal
1
1
45-52
Anti-Inflammatory Agents, Non-Steroidal/adverse effects
Anti-Inflammatory Agents, Non-Steroidal/therapeutic use
Arthritis, Rheumatoid/drug therapy
Aspirin/adverse effects
Aspirin/therapeutic use
Cardiovascular Diseases/chemically induced
Cardiovascular Diseases/epidemiology
Cardiovascular Diseases/mortality
Celecoxib
Clinical Trials as Topic
Cyclooxygenase Inhibitors/adverse effects
Cyclooxygenase Inhibitors/therapeutic use
Humans
Lactones/adverse effects
Lactones/therapeutic use
Osteoarthritis/drug therapy
Pyrazoles
Risk Factors
Sulfonamides/adverse effects
Sulfonamides/therapeutic use
Sulfones
eng
60_published
peer-reviewed
Publication types: Journal Article ; Review
Publication Status: ppublish